thromboxanes has been researched along with Colonic Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boedtkjer, E; Kold-Petersen, H; Voss, NCS | 1 |
| Baba, M; Nishino, H; Okuyama, T; Takahashi, T | 1 |
| Kelloff, G; Rao, CV; Reddy, BS; Rivenson, A; Simi, B; Steele, V; Zang, E | 1 |
| FitzGerald, GA; Narumiya, S | 1 |
| Fernandes, G; Flescher, E; Guzman, RF; Mason, AD; Pruitt, BA; Venkatraman, J; Waymack, JP; Yurt, RW | 1 |
1 review(s) available for thromboxanes and Colonic Neoplasms
| Article | Year |
|---|---|
Genetic and pharmacological analysis of prostanoid receptor function.
Topics: Animals; Aspirin; Biological Transport; Bone Resorption; Cell Nucleus; Colonic Neoplasms; Cyclooxygenase Inhibitors; Drug Design; Female; Fever; GTP-Binding Proteins; Humans; Hypersensitivity; Inflammation; Ischemia; Mice; Mice, Knockout; Neovascularization, Pathologic; Pain; Placenta; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Protein Structure, Tertiary; Receptors, Prostaglandin; Receptors, Thromboxane; Signal Transduction; Thromboxanes; Vasodilation | 2001 |
4 other study(ies) available for thromboxanes and Colonic Neoplasms
| Article | Year |
|---|---|
Enhanced nitric oxide signaling amplifies vasorelaxation of human colon cancer feed arteries.
Topics: Acetylcholine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Arteries; Colonic Neoplasms; Endothelin-1; Female; Humans; Male; Middle Aged; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Thromboxanes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2019 |
Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Caspases; Chalcone; Chalcones; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Mice; Plants; Poly(ADP-ribose) Polymerases; Prostaglandins; Thromboxanes; Tumor Cells, Cultured | 2006 |
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Hydroxyeicosatetraenoic Acids; Male; Pharmaceutical Vehicles; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Diacylglycerol-Lyase; Phosphatidylinositol Phosphates; Phosphoinositide Phospholipase C; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Prostaglandins; Rats; Rats, Inbred F344; Sulindac; Thromboxanes | 1995 |
The effect of elevated levels of thromboxane on host response to tumor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Colonic Neoplasms; Fibrosarcoma; Humans; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Male; Neoplasm Transplantation; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred F344; Rats, Inbred WF; T-Lymphocyte Subsets; Thromboxanes | 1992 |